Cwestiwn ysgrifenedig WQ97554
- Gofynnwyd gan
- Delyth JewellPlaid
- I'w ateb gan
- Cabinet Secretary for Health and Social Care
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 11 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
How much Welsh Government cancer research spend has been allocated to each of the less survivable cancers: brain, liver, lung, oesophageal, pancreatic, and stomach since 2022, and what proportion of the total spend into cancer research is this?
Ateb
Atebwyd gan Cabinet Secretary for Health and Social Care
The Welsh Government is committed to improving cancer outcomes and recognises the importance of a strong cancer research base.
Each year, Welsh Government provides the NHS with approximately £18m to fund an extensive Wales-wide research delivery infrastructure – including dedicated healthcare professionals – to support patient participation in clinical trials. The resources required for each study vary. Individual cost breakdowns at study level are not collected.
Since April 2022:
• There have been 378 cancer studies open in Wales, 25% of the 1,539 portfolio studies open during that period.
• There were 81 open studies relating to brain, liver, lung, oesophageal, pancreatic or stomach cancer, 21% of total cancer studies.
Through our direct Health and Care Research funding schemes, £3.94m has been allocated to 14 cancer studies since 2021-22:
Less survivable cancers
Number of awards
Amount of funding
Brain
1
£166k
Lung
1
£230k
Stomach
1
£136k
Other cancers
Blood
1
£66k
Bowel
2
£259k
Breast
2
£604k
Cervical screening
1
£538k
Kidney
1
£453k
Lymphoma
1
£286k
Prostate
1
£600k
Skin
1
£250k